NDC Package 73377-262-01 Ruxolitinib Phosphate

Powder - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
73377-262-01
Package Description:
100 g in 1 PACKAGE
Product Code:
Non-Proprietary Name:
Ruxolitinib Phosphate
Substance Name:
Ruxolitinib Phosphate
Usage Information:
This medication is used to treat certain bone marrow disorders (myelofibrosis, polycythemia vera). It works by blocking your body from producing substances called growth factors. Growth factors cause cells to grow and divide, and cause the blood cell and spleen problems found in these disorders. Ruxolitinib belongs to a class of drugs known as kinase inhibitors. Though not a cure for these disorders, ruxolitinib may help with some of the symptoms, including abdominal discomfort, pain under left ribs, early feelings of fullness from meals, night sweats, itching, and bone/muscle pain. Ruxolitinib is also used to treat a certain problem that may occur after certain stem cell or bone marrow transplants (graft versus host disease). It works by weakening your body's defense system (immune system).
11-Digit NDC Billing Format:
73377026201
Product Type:
Bulk Ingredient
Labeler Name:
Ax Pharmaceutical Corp
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
Sample Package:
N/A
Marketing Category:
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING - A category specifying that a bulk product is intended for use on humans and requires a prescription.
Start Marketing Date:
01-30-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 73377-262-01?

The NDC Packaged Code 73377-262-01 is assigned to an UNFINISHED drug package of 100 g in 1 package of Ruxolitinib Phosphate, a bulk ingredient labeled by Ax Pharmaceutical Corp. The product's dosage form is powder and is administered via form.

Is NDC 73377-262 included in the NDC Directory?

Yes, Ruxolitinib Phosphate is an UNFINISHED PRODUCT with code 73377-262 that is active and included in the NDC Directory. The product was first marketed by Ax Pharmaceutical Corp on January 30, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 73377-262-01?

The 11-digit format is 73377026201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-273377-262-015-4-273377-0262-01